COVID-19 infections are also affected by human ACE1 D/I polymorphism
- PMID: 32286246
- DOI: 10.1515/cclm-2020-0425
COVID-19 infections are also affected by human ACE1 D/I polymorphism
Keywords: COVID-19; angiotensin-converting enzyme; plasma proteins; polymorphism.
Comment in
-
No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.Clin Chem Lab Med. 2020 Jun 25;58(7):1127-1128. doi: 10.1515/cclm-2020-0577. Clin Chem Lab Med. 2020. PMID: 32386188 No abstract available.
-
Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?Croat Med J. 2020 Dec 31;61(6):525-526. doi: 10.3325/cmj.2020.61.525. Croat Med J. 2020. PMID: 33410299 Free PMC article. No abstract available.
-
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.002. Epub 2021 Jun 16. J Infect. 2021. PMID: 34097930 Free PMC article. No abstract available.
References
-
- Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton University Press: Princeton, NJ, USA, 1994:1–1088.
-
- Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cell Mol Dis 2003;31:262–7.
-
- Saab YB, Gard P, Overall A. The geographic distribution of the ACE II genotype: a novel finding. Genet Res 2007;89:259–67.
-
- www.worldometers.info/coronavirus/countries. Assessed March 28, 2020.
-
- Delanghe JR, Speeckaert R, Speeckaert MM. Complement C3 and its polymorphism: biological and clinical consequences. Pathology 2014;46:1–10.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous